Back to Search
Start Over
Exploring the role of circulating VE-cadherin (VE-C) in metastatic colorectal adenocarcinoma (mCA) patients (pts) treated by bevacizumab (Bev)
- Source :
- Journal of Clinical Oncology, Journal of Clinical Oncology, American Society of Clinical Oncology, 2014, 32 (15_suppl), pp.e14614-e14614, Journal of Clinical Oncology, 2014, 32 (15_suppl), pp.e14614-e14614. ⟨10.1200/jco.2014.32.15_suppl.e14614⟩
- Publication Year :
- 2014
- Publisher :
- HAL CCSD, 2014.
-
Abstract
- e14614^ Background: No predictive biomarker of tumor response or resistance to Bev has been identified in mCA. VE-C is an endothelium-specific adhesion molecule of vital importance for endothelium ...
- Subjects :
- Cancer Research
Pathology
medicine.medical_specialty
Bevacizumab
Endothelium
business.industry
[SDV.CAN]Life Sciences [q-bio]/Cancer
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Tumor response
3. Good health
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
cardiovascular system
medicine
Cancer research
Colorectal adenocarcinoma
VE-cadherin
business
ComputingMilieux_MISCELLANEOUS
030215 immunology
medicine.drug
Predictive biomarker
Subjects
Details
- Language :
- English
- ISSN :
- 0732183X and 15277755
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology, Journal of Clinical Oncology, American Society of Clinical Oncology, 2014, 32 (15_suppl), pp.e14614-e14614, Journal of Clinical Oncology, 2014, 32 (15_suppl), pp.e14614-e14614. ⟨10.1200/jco.2014.32.15_suppl.e14614⟩
- Accession number :
- edsair.doi.dedup.....09f26819a4dae51691333eeafc27f6dc